RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Cambridge Nutritional Sciences ROA 2024

Cambridge Nutritional Sciences ROA

-0.27

Cambridge Nutritional Sciences Dividend yield

Ticker

CNSL.L

ISIN

GB00B1VCP282

WKN

A0MYRK

In 2024, Cambridge Nutritional Sciences's return on assets (ROA) was -0.27, a -57.83% increase from the -0.64 ROA in the previous year.

Cambridge Nutritional Sciences Aktienanalyse

What does Cambridge Nutritional Sciences do?

Omega Diagnostics Group PLC is a British company specializing in the development, manufacture, and sale of diagnostic tests and systems. It was founded in 1987 and is headquartered in Scotland. Omega Diagnostics Group focuses on developing tests and diagnostic devices for infectious diseases, autoimmune diseases, and allergic diseases. Omega Diagnostics is a global company with subsidiaries in a dozen countries and a customer base in over 100 countries. The company is listed on the London Stock Exchange and is one of the leading companies in the field of diagnostic tests. The company has three main divisions that can be used independently or in combination to solve complex diagnostic questions: 1. Allergy diagnostics: In this division, Omega Diagnostics offers tests that enable doctors to identify the causes of allergies and intolerances. Omega Diagnostics works closely with leading allergists to develop innovative tests that are fast and reliable. 2. Autoimmune diagnostics: Omega Diagnostics also develops and manufactures tests specifically targeting autoimmune diseases. The tests help to detect and treat autoimmune diseases such as lupus, rheumatoid arthritis, or multiple sclerosis at an early stage. 3. Infection diagnostics: Omega Diagnostics' infection diagnostics division specializes in the development and sale of accurate and reliable tests for diagnosing infectious diseases such as HIV, hepatitis, or tuberculosis. In addition to its divisions, the company also develops other products such as immunoassays and fluorescence measurement devices. Furthermore, the company offers a product line for monitoring and controlling food and allergens in the food industry. Omega Diagnostics' business model is based on the development and manufacture of diagnostic tests and devices used in hospitals, clinics, laboratories, and pharmacies. Additionally, the company collaborates with pharmaceutical companies and research institutions to develop innovative medical solutions. In recent years, Omega Diagnostics has successfully developed and introduced new technologies to the market. The company has particularly responded to the growing demand for diagnostic tests in the field of epidemiology. An example of this is the COVID-19 antigen rapid test system, which the company recently introduced and allows for the rapid identification of SARS-CoV-2 in a variety of patients. Overall, Omega Diagnostics has a strong focus on researching and developing new and improved diagnostic test methods. The company is committed to developing innovative technologies that can make the medical treatment process more effective and efficient. With its strong presence in the global market and the ability to quickly respond to new developments, Omega Diagnostics is a rising company that has successfully positioned itself in an innovation-driven sector. Cambridge Nutritional Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Cambridge Nutritional Sciences's Return on Assets (ROA)

Cambridge Nutritional Sciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Cambridge Nutritional Sciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Cambridge Nutritional Sciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Cambridge Nutritional Sciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Cambridge Nutritional Sciences Stock

What is the Return on Assets (ROA) of Cambridge Nutritional Sciences this year?

The Return on Assets (ROA) of Cambridge Nutritional Sciences is -0.27 undefined this year.

What was the ROA of Cambridge Nutritional Sciences compared to the previous year?

The ROA of Cambridge Nutritional Sciences has increased by -57.83% compared to the previous year.

What consequences do high ROA have for investors of Cambridge Nutritional Sciences?

A high ROA is advantageous for investors of Cambridge Nutritional Sciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Cambridge Nutritional Sciences?

A low ROA can be unfavorable for investors of Cambridge Nutritional Sciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Cambridge Nutritional Sciences affect the company?

An increase in ROA of Cambridge Nutritional Sciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Cambridge Nutritional Sciences impact the company?

A reduction in the ROA of Cambridge Nutritional Sciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Cambridge Nutritional Sciences?

Some factors that can influence the ROA of Cambridge Nutritional Sciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Cambridge Nutritional Sciences important for investors?

The ROA of Cambridge Nutritional Sciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Cambridge Nutritional Sciences take to improve ROA?

To improve ROA, Cambridge Nutritional Sciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Cambridge Nutritional Sciences pay?

Over the past 12 months, Cambridge Nutritional Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cambridge Nutritional Sciences is expected to pay a dividend of 0 GBP.

What is the dividend yield of Cambridge Nutritional Sciences?

The current dividend yield of Cambridge Nutritional Sciences is .

When does Cambridge Nutritional Sciences pay dividends?

Cambridge Nutritional Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cambridge Nutritional Sciences?

Cambridge Nutritional Sciences paid dividends every year for the past 0 years.

What is the dividend of Cambridge Nutritional Sciences?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cambridge Nutritional Sciences located?

Cambridge Nutritional Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cambridge Nutritional Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cambridge Nutritional Sciences from 5/31/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Cambridge Nutritional Sciences pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Cambridge Nutritional Sciences in the year 2023?

In the year 2023, Cambridge Nutritional Sciences distributed 0 GBP as dividends.

In which currency does Cambridge Nutritional Sciences pay out the dividend?

The dividends of Cambridge Nutritional Sciences are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cambridge Nutritional Sciences

Our stock analysis for Cambridge Nutritional Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cambridge Nutritional Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.